Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CLDXCLDX
30 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Celldex Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC holds 2M shares of CLDX (Celldex Therapeutics, Inc.), worth $75.3M as of 2026-Q2. The position was increased (+19.8% shares). CLDX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$75.3M

Current Shares

2M

Total Value Change

+$74.7M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+19.8%
$75.3M0.0%$37.21
35
2026-Q1
Increased
1.7M
+3.7%
$53.6M0.0%$28.94
30
2025-Q4
Decreased
1.6M
-1.2%
$44.2M0.0%$26.43
0
2025-Q3
Decreased
1.6M
-1.5%
$42.6M0.0%$26.19
0
2025-Q2
Increased
1.7M
+5.2%
$34M0.0%$20.29
30
2025-Q1
Increased
1.6M
+3.6%
$28.9M0.0%$19.93
30
2024-Q4
Decreased
1.5M
-0.4%
$38.8M0.0%$25.12
0
2024-Q3
Increased
1.5M
+0.4%
$52.4M0.0%$33.20
29
2024-Q2
Increased
1.5M
+8.4%
$56.8M0.0%$37.01
32
2024-Q1
Increased
1.4M
+26.5%
$59.4M0.0%$41.97
36
2023-Q4
Increased
1.1M
+11.8%
$44.3M0.0%$39.66
33
2023-Q3
Increased
1M
+3.7%
$27.5M0.0%$27.52
30
2023-Q2
Increased
965,073
+4.3%
$32.7M0.0%$34.58
30
2023-Q1
Increased
925,708
+4.8%
$33.3M0.0%$35.58
30
2022-Q4
Increased
883,535
+3.6%
$39.4M0.0%$44.57
30
2022-Q3
Increased
852,706
+1.4%
$24M0.0%$28.35
29
2022-Q2
Decreased
841,124
-1.7%
$22.7M0.0%$27.83
0
2022-Q1
Increased
855,513
+5.6%
$29.1M0.0%$34.59
30
2021-Q4
Increased
810,420
+2.3%
$31.3M0.0%$38.90
29
2021-Q3
Increased
792,507
+17.8%
$42.8M0.0%$51.97
34
2021-Q2
Increased
672,948
+90.8%
$22.5M0.0%$35.37
45
2021-Q1
Increased
352,697
+17.9%
$7.3M0.0%$19.73
32
2020-Q4
Increased
299,054
+16.1%
$5.2M0.0%$17.88
31
2020-Q3
Increased
257,629
+97.8%
$3.8M0.0%$15.19
43
2020-Q2
Increased
130,237
+25.3%
$1.7M0.0%$12.48
32
2020-Q1
Decreased
103,983
-50.0%
$172,0000.0%$1.77
0
2019-Q4
Increased
207,966
+101.5%
$462,0000.0%$2.20
26
2019-Q3
Unchanged
103,193
0.0%
$219,0000.0%$2.17
0
2019-Q2
Decreased
103,193
-4.7%
$276,0000.0%$2.68
0
2019-Q1
New
108,305
-
$532,0000.0%$4.92
34

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used